Hormone Pulse Therapy Effective Against MS
A new study has suggested that hormone pulse therapy can help in curing Multiple Sclerosis (MS) in people who are unable to benefit from the conventional treatment they receive.
As many as 23 MS patients took part in study and these were the patients who were undergoing beta-interferon treatment for the condition. It was learnt that these patients had at least one relapse and a new disease activity within last year.
They were reported to become immune to the treatment and its effectiveness decreased causing their condition to worsen. They were, thus, given adrenocorticotropic hormone (ACTH) or methylprednisolone under the new pulse therapy along with the traditional treatment they were undergoing.
The participants were then assessed after every three months for a time span of 15 months. It was seen that patients undergoing ACTH therapy had 0.08 relapses per patient and those undergoing methylprednisolone had 0.8 relapses per patient.
"Further studies, including randomized controlled trials, are needed to validate these preliminary findings, but the results suggest a potential benefit of ACTH pulse therapy in breakthrough MS", said Regina Berkovich, MD, PhD, of Keck Medical Center of USC in Los Angeles, who was Lead Author of the study.
The study will be presented at the American Academy of Neurology's annual meeting beginning on March 16.
New Zealand News
- What Does Phasing Out Cheques Tell Us About Finance in New Zealand?
- South Korean casino operator GKL closes third casino amid soaring cases of COVID-19
- Top Live Casinos in India and Pure Casino Signup Offer
- Independent MP Justin Field making efforts to prevent NSW from compensating Crown Resorts
- President-elect Biden’s Climate Plan to provide big boost to EVs and green power